CD4 +foxp3 + T-regulatory cells in noninfectious uveitis

Archives of Ophthalmology

Volumn 127, Issue 4, 2009, Pages 407-413

  Yeh, Steven ^a   Li, Zhuqing ^a   Forooghian, Farzin ^a,b   Hwang, Frank S ^a   Cunningham, Matthew A ^a   Pantanelli, Seth ^a   Lew, Julie C ^a   Wroblewski, Keith K ^a,c   Vitale, Susan ^b   Nussenblatt, Robert B ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; ETANERCEPT; INFLIXIMAB; MESSENGER RNA; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECOMMENDED DRUG DOSE; REGULATORY T LYMPHOCYTE; RETINA MACULA CYSTOID EDEMA; SCLERITIS; UVEITIS; VISUAL ACUITY; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; ANTIGENS, CD4; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; UVEITIS; YOUNG ADULT;

EID: 65249162362     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.32     Document Type: Article

References (33)

1. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990;14(5-6):303-308.
2. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004; 111(3):491-500.
3. Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease. CurrEye Res. 2001; 22(4):312-318.
4. Caspi RR, Roberge FG, McAllister CG, et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol. 1986;136(3):928-933.
5. Takase H, Sugita S, Taguchi C, Imai Y, Mochizuki M. Capacity of ocular infiltrating T helper type 1 cells of patients with non-infectious uveitis to produce chemokines. Br J Ophthalmol. 2006;90(6):765-768.
6. Takase H, Yu CR, Ham DI, et al. Inflammatory processes triggered byTCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations. JLeukocBiol. 2006;80(3):538-545.
7. + T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol. 2007;36(6):428-433.
8. Alvarado-Sánchez B, Hernández-Castro B, Portalés-Perez D, et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun. 2006;27 (2):110-118.
9. Idali F, Wahlstrom J, Muller-Suur C, Eklund A, Grunewald J. Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol. 2008;152(1):127-137.
10. Miyara M, Amoura Z, Parizot C, et al. The immune paradox of sarcoidosis and regulatoryTcells. JExpMed. 2006;203(2):359-370.
11. Valencia X, Lipsky PE. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol. 2007;3(11):619-626.
12. Kumar M, PutzkiN, Limmroth V, et al. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. JNeuroimmunol. 2006;180(1-2):178-184.
13. Huan J, Culbertson N, Spencer L, et al. Decreased FOXP3 levels in multiple sclerosis patients. JNeurosciRes. 2005;81(1):45-52.
14. suphigh regulatory Tcells associated with active uveitis in Vogt-Koyanagi-Harada syndrome [published online ahead of print April 17, 2008]. Invest Oph-thalmolVis Sci. 2008;49(8):3475-3482.
15. Hamzaoui K, Hamzaoui A, Houman H. CD4+CD25+ regulatory T cells in patients with Behcet's disease. Clin Exp Rheumatol. 2006;24(5)(suppl 42):S71-S78.
16. Silver PB, Agarwal RK, Su SB, et al. Hydrodynamic vaccination with DNAencoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J Immunol. 2007;179(8):5146-5158.
17. Keino H, Takeuchi M, Usui Y, et al. Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis. Br J Ophthalmol. 2007;91(1):105-110.
18. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057-1061.
19. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol. 2003;4(4):330-336.
20. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-516.
21. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985; 92(4):467-471.
22. Li Z, Mahesh SP, Kim BJ, Buggage RR, Nussenblatt RB. Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. JAutoimmun. 2003;21(1):83-92.
23. Li Z, Lim WK, Mahesh SP, Liu B, Nussenblatt RB. Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J Immunol. 2005;174(9):5187-5191.
24. + regulatory T cells. Immunol Rev. 2006;212:60-73.
25. Commodaro A, Peron JPS, Macedo A, Arslanian C, Muccioli C, Rizzo LV, Belfort R Jr. Characterization of T regulatory cells and cytokine profile in peripheral blood of patients with Vogt-Koyanagi-Harada disease (VKH) and autoimmune uveitis [ARVO abstract 3232]. Clin Med Res. 2008;49:e-abstract 3232.
26. Siepmann K, BiesterS, PlskovaJ, Muckersie E, Duncan L, Forrester JV. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo. Graefes Arch Clin Exp Ophthalmol. 2007;245(2):221-229.
27. Peng Y, Shao H, Ke Y, et al. Minimally activated CD8 autoreactive Tcells specific for IRBP express a high level of Foxp3 and are functionally suppressive. Invest Ophthalmol Vis Sci. 2007;48(5):2178-2184.
28. Costantino CM, Baecher-Allan CM, Hafler DA. Human regulatory T cells and autoimmunity. Eur J Immunol. 2008;38(4):921-924.
29. Baráth S, Sipka S, Aleksza M, et al. RegulatoryT cells in peripheral blood of patients with mixed connective tissue disease. Scand J Rheumatol. 2006;35(4): 300-304.
30. Abdulahad WH, Stegeman CA, van derGeld YM, Doornbos-van derMeer B, Lim- burg PC, Kallenberg CG. Functional defect of circulating regulatory CD4 + Tcells in patients with Wegener's granulomatosis in remission. Arthritis Rheum. 2007; 56(6):2080-2091.
31. RothovaA. Inflammatory cystoid macular edema. CurrOpin Ophthalmol. 2007; 18(6):487-492.
32. Fine HF, Baffi J, Reed GF, Csaky KG, Nussenblatt RB. Aqueous humorand plasma vascularendothelial growth factorin uveitis-associated cystoid macularedema. Am J Ophthalmol. 2001;132(5):794-796.
33. van AmelsfortJM, Jacobs KM, Bijlsma JW, LafeberFP,Taams LS. CD4(+)CD25 (+) regulatory T cells in rheumatoid arthritis: differences in the presence, phe- notype, and function between peripheral blood and synovial fluid. ArthritisRheum.2004;50(9):2775-2785.